Zdrowie i gospodarka · 06/02/2012
FDA Adopts Final Rule on Labeling Requirements for Products in Strategic National Stockpile
The FDA is finalizing a rule allowing FDA Center Directors to grant exceptions or alternatives to certain labeling requirements for human drugs, biological products, or medical devices held in the Strategic National Stockpile.
Source: Federal Register — Food and Drug AdministrationOpen original release →